To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin
Clinical trial NCT05162014 · COMPLETED
Trial details
- NCT number
- NCT05162014
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-20
- Primary completion
- 2022-09-12
- Enrollment
- 494679
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.